Director, President and CEO · OnKure Therapeutics, Inc. · Class A Common Stock
Side
SELL
Value
$259
Shares
87
Price
$2.97
Executed
Sep 21, 2026
Disclosed
Sep 23, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 21 executedSep 23, 2026 disclosed
OKUR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Saccomano Nicholas A filed this Form 4 reporting a open-market sale of OKUR on Sep 21, 2026. It became public on Sep 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Saccomano Nicholas Acik:0001609284
Issuer
OnKure Therapeutics, Inc.cik:0001637715
Revision history · 0
No field has changed since this record was first ingested.
